Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Broadcom
AVGO
|
$946M |
| 2 |
Intuitive Surgical
ISRG
|
$917M |
| 3 |
Microsoft
MSFT
|
$831M |
| 4 |
Schlumberger
SLB
|
$729M |
| 5 |
UnitedHealth
UNH
|
$644M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$1.92B |
| 2 |
XYZ
Block, Inc.
XYZ
|
$1.35B |
| 3 |
Shopify
SHOP
|
$1.23B |
| 4 |
Sea Limited
SE
|
$975M |
| 5 |
Atlassian
TEAM
|
$769M |
Sector Composition
| 1 | Technology | 31.62% |
| 2 | Consumer Discretionary | 25.37% |
| 3 | Communication Services | 11.39% |
| 4 | Healthcare | 11.27% |
| 5 | Financials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Agilon Health
AGL
$497M
| – | – |
-630,534
| Closed | -$17M |
|
|
ALLK
627
DELISTED
Allakos
ALLK
| – | – |
-270,532
| Closed | -$2.65M |
|
628
Antero Midstream
AM
$8.73B
| – | – |
-392,589
| Closed | -$3.8M |
|
|
AMED
629
DELISTED
Amedisys
AMED
| – | – |
-28,667
| Closed | -$4.64M |
|
630
Artisan Partners
APAM
$3.26B
| – | – |
-19,751
| Closed | -$941K |
|
631
Aramark
ARMK
$10.2B
| – | – |
-79,621
| Closed | -$2.12M |
|
632
Altice USA
ATUS
$1.05B
| – | – |
-167,663
| Closed | -$2.71M |
|
633
Avery Dennison
AVY
$13.1B
| – | – |
-59,583
| Closed | -$12.9M |
|
|
AZEK
634
DELISTED
The AZEK Co
AZEK
| – | – |
-951,418
| Closed | -$44M |
|
635
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$42B
| – | – |
-2,778
| Closed | -$254K |
|
636
Buckle
BKE
$3.03B
| – | – |
-28,504
| Closed | -$1.21M |
|
|
BPMC
637
DELISTED
Blueprint Medicines
BPMC
| – | – |
-251,237
| Closed | -$26.9M |
|
638
Bruker
BRKR
$4.68B
| – | – |
-10,732
| Closed | -$901K |
|
639
Cable One
CABO
$922M
| – | – |
-516
| Closed | -$910K |
|
640
Cadence Bank
CADE
$7.04B
| – | – |
-61,551
| Closed | -$1.83M |
|
641
C4 Therapeutics
CCCC
$194M
| – | – |
-27,001
| Closed | -$869K |
|
642
CDW
CDW
$22.2B
| – | – |
-4,353
| Closed | -$891K |
|
643
C.H. Robinson
CHRW
$14.9B
| – | – |
-19,904
| Closed | -$2.14M |
|
644
CRISPR Therapeutics
CRSP
$4.99B
| – | – |
-409,683
| Closed | -$31M |
|
645
Curtiss-Wright
CW
$18.1B
| – | – |
-132,291
| Closed | -$18.3M |
|
646
Community Health Systems
CYH
$409M
| – | – |
-71,550
| Closed | -$952K |
|
647
CryoPort
CYRX
$518M
| – | – |
-226,659
| Closed | -$13.4M |
|
648
Caesars Entertainment
CZR
$5.48B
| – | – |
-16,219
| Closed | -$1.52M |
|
649
Endava
DAVA
$553M
| – | – |
-12,628
| Closed | -$2.12M |
|
650
3D Systems Corporation
DDD
$272M
| – | – |
-61,524
| Closed | -$1.33M |
|